Nathan A. Furr

Statistics

Publications

Citations

H-Index

Active since

2013

Affiliations

Nathan A. Furr is an author at Eli Lilly (United States) specializing in drug disposition, clinical pharmacokinetics, and metabolite pharmacokinetics.

Publications per year

2013–2013

Publications

Pharmacokinetics, Metabolism, and Excretion of the Glycogen Synthase Kinase-3 Inhibitor LY2090314 in Rats, Dogs, and Humans: A Case Study in Rapid Clearance by Extensive Metabolism with Low Circulating Metabolite Exposure

Maciej J. Zamek‐Gliszczynski, Trent L. Abraham, Jeffrey J. Alberts et al. · Drug Metabolism and Disposition · 2013 · 39 citations · Full text

Medicine, Clinical Pharmacokinetics, Pharmacology +15

1–1 of 1